Gamma-hydroxybutyrate (GHB) in humans: pharmacodynamics and pharmacokinetics.
about
Behavioral analyses of GHB: receptor mechanismsBehavioral effects of gamma-hydroxybutyrate in humansBritish Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders.Sodium oxybate for the treatment of fibromyalgia.The clinical toxicology of γ-hydroxybutyrate, γ-butyrolactone and 1,4-butanediol.Intravenous self-administration of γ-hydroxybutyrate (GHB) in baboonsGHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome.Preference for gamma-hydroxybutyrate (GHB) in current users.Pharmacodynamic interactions of a solid formulation of sodium oxybate and ethanol in healthy volunteers.Pharmacokinetics and pharmacodynamics of γ-hydroxybutyrate in healthy subjects.Presentations to an urban emergency department in Switzerland due to acute γ-hydroxybutyrate toxicity.Gamma-hydroxybutyric acid in male and female cynomolgus monkeys trained to discriminate 1.0 or 2.0 g/kg ethanol.Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuse.Cognitive, psychomotor, and subjective effects of sodium oxybate and triazolam in healthy volunteersMonocarboxylate Transporter Inhibition with Osmotic Diuresis Increases γ-Hydroxybutyrate Renal Elimination in Humans: A Proof-of-Concept Study.Retrospective drug detection in cases of drug-facilitated sexual assault: challenges and perspectives for the forensic toxicologist.Reconsidering GHB: orphan drug or new model antidepressant?Screening and confirmation methods for GHB determination in biological fluids.Gamma-hydroxybutyrate and cocaine intoxication in a Danish child.Mechanisms for the Specific Properties of γ-Hydroxybutyrate in Brain.Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention.Feasibility of following up gamma-hydroxybutyric acid concentrations in sodium oxybate (Xyrem®)-treated narcoleptic patients using dried blood spot sampling at home: an exploratory study.Measuring the subjective: revisiting the psychometric properties of three rating scales that assess the acute effects of hallucinogens.Novel Psychoactive Substances-Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs.Do capillary dried blood spot concentrations of gamma-hydroxybutyric acid mirror those in venous blood? A comparative study.Pharmacokinetic properties of γ-hydroxybutyrate (GHB) in whole blood, serum, and urine.Gamma-hydroxybutyric acid (GHB) measurement by GC-MS in blood, urine and gastric contents, following an acute intoxication in Belgium.Increases in Serum Growth Hormone Concentrations Associated with GHB Administration.Analysis of γ-hydroxy butyrate by combining capillary electrophoresis-indirect detection and wall dynamic coating: application to dried matrices.Neuronal oscillations and synchronicity associated with gamma-hydroxybutyrate during resting-state in healthy male volunteers.Gamma-Hydroxybutyrate Increases Resting-State Limbic Perfusion and Body and Emotion Awareness in Humans.Dried blood spot punches for confirmation of suspected γ-hydroxybutyric acid intoxications: validation of an optimized GC-MS procedure.Effect of GHB-use and GHB-induced comas on dorsolateral prefrontal cortex functioning in humans
P2860
Q24645147-B0D41612-F237-4139-AB54-918A21DC8D15Q34026042-E843411B-1574-48ED-AFFB-8C4D1533F2AFQ34135759-36A4AEC1-6450-4145-B900-E24A53B24037Q34193082-9E3C1850-92CE-412F-A3DB-F741376F565EQ34285013-F3179B4B-181C-423C-A34A-29EAE3C97FBFQ34630587-C4C508E0-F1D0-4EE4-8C9B-1DAEA492B0F5Q35710620-24E7A5CD-3F92-4263-B7F4-D245FB65BD42Q36025811-847C5C07-BACF-4E7D-976F-9EE3CB0E719EQ36072485-331689C5-5D4F-48B6-950C-49C7E9C4D7BFQ36806659-99A27A10-C807-48B9-A7A9-34202507FDBFQ37224304-DD0DD6F1-1971-49C7-88C0-F1A86E1F1965Q37246216-62597D5B-9792-4215-8187-24E172B7FC05Q37268694-23F3BC59-AABD-475E-9230-5BE9A64AFC0AQ37472845-F76970EF-9ECD-4E0E-B51C-5CF049DF1372Q37723326-835ED553-723E-4588-893D-15597F7B59EBQ37810147-9EB9DE87-602B-472B-BE75-D417F6F57723Q37934335-F9C954D4-02D0-4EAF-8E32-3BFF224240DFQ38185603-964CE2B0-1CFF-4203-B658-21EB02D74B0BQ38685831-B57CB8B0-F9D5-445C-95B3-664D3B221EF5Q38688873-8A6161F4-5D8A-4E19-ACD0-03F473874FE5Q39048315-25AED014-CB57-4326-BC73-60644F87FE75Q39456871-EBE24CB7-6D48-4D20-887A-8E6595D9E9C5Q39548034-89D4D848-9FDD-4CA4-A3A0-14F48BAF1C64Q41462770-AE97812F-BE0A-4F09-A9BF-F024D1366B6AQ41615219-0B5AFDAB-C2AF-4794-954F-410494D72369Q43450955-7D7A1F8C-1237-457F-B0B3-70496595A1E6Q44597346-82ACCB92-DEFD-4DBF-A61E-A24E3FC69FF0Q47378973-4D16220C-54DC-4410-AA10-3A0B49B6D898Q47645271-8889A2B0-4D6B-44A7-96C2-0EFF6A539EE5Q47739628-87CF2EAC-097E-4262-A207-CE91E583F7E0Q48352347-C2285B24-170E-4C54-8287-9838007F915CQ49044992-5D6DA064-BA61-46EA-AD8F-56BBF881D586Q57299896-D6AF9087-8484-432E-A5A2-6A4B88A8EC04
P2860
Gamma-hydroxybutyrate (GHB) in humans: pharmacodynamics and pharmacokinetics.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Gamma-hydroxybutyrate (GHB) in humans: pharmacodynamics and pharmacokinetics.
@en
Gamma-hydroxybutyrate
@nl
type
label
Gamma-hydroxybutyrate (GHB) in humans: pharmacodynamics and pharmacokinetics.
@en
Gamma-hydroxybutyrate
@nl
prefLabel
Gamma-hydroxybutyrate (GHB) in humans: pharmacodynamics and pharmacokinetics.
@en
Gamma-hydroxybutyrate
@nl
P2093
P2860
P50
P356
P1476
Gamma-hydroxybutyrate (GHB) in humans: pharmacodynamics and pharmacokinetics
@en
P2093
Diego Barral
Magi Farré
Mireia Segura
Roberta Pacifici
Sergio Abanades
P2860
P304
P356
10.1196/ANNALS.1369.065
P577
2006-08-01T00:00:00Z